Asset Details
Do you wish to reserve the book?
Photobiomodulation therapy compensate the impairments of diabetic bone marrow mesenchymal stem cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Photobiomodulation therapy compensate the impairments of diabetic bone marrow mesenchymal stem cells
Do you wish to request the book?
Photobiomodulation therapy compensate the impairments of diabetic bone marrow mesenchymal stem cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Photobiomodulation therapy compensate the impairments of diabetic bone marrow mesenchymal stem cells
2020
Overview
Pathophysiologic conditions associated with diabetes mellitus affect mesenchymal stem cells (MSCs), and this phenomenon may lead to some diabetic secondary complications. The present study was conducted to evaluate the impact of photobiomodulation (PBM) on rat diabetic MSC (DMSC) behavior in vitro. For the purpose of PBM, we used helium-neon laser with a wavelength of 632.8 nm at three different energy densities (0.5, 1, 2 J/cm
2
) and radiation periodicity of once, twice, and thrice. The survival, proliferation, and apoptosis in the normal MSCs (NMSCs), DMSCs, and diabetic MSCs, which were laser irradiated (DMSCs+L), were assessed using MTT assay, Ki67 immunofluorescence staining, and TUNEL assay, respectively. Our results demonstrated that DMSCs have significantly lower survival (
P
< 0.05) and proliferation rates (
P
< 0.001), and dramatically higher population doubling time (PDT,
P
< 0.001) and apoptosis rates (
P
< 0.001) as compared to NMSCs. Moreover, PBM with energy density of 1 J/cm
2
and the periodicity of 1 or 2 times could improve diabetic MSC capabilities in the term of survival, proliferation, and apoptosis. Considering these findings, it is suggested that PBM could improve the ability of diabetic MSCs in vitro prior to transplantation or may rise their capabilities in their native niche in vivo.
Publisher
Springer London,Springer Nature B.V
Subject
/ Apoptosis - radiation effects
/ Cell Proliferation - radiation effects
/ Cell Survival - radiation effects
/ Diabetes
/ Diabetes Mellitus - pathology
/ Diabetes Mellitus - radiotherapy
/ Helium
/ Lasers
/ Male
/ Medicine
/ Mesenchymal Stem Cells - pathology
/ Mesenchymal Stem Cells - radiation effects
/ Neon
/ Optics
/ Rats
/ Survival
